Atlas Trials

Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer

Clinical trial NCT00854620 · COMPLETED

Trial details

NCT number
NCT00854620
Sponsor
Stanford University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Renal CellKidney DiseaseKidney Cancer
Start date
2007-12-01
Primary completion
2009-07-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.